Concentrix Corporation (FRA:CO8)

Intra-Cellular Therapies Revenue

Concentrix had revenue of $2.42B USD in the quarter ending May 31, 2025, with 1.54% growth. This brings the company's revenue in the last twelve months to $9.63B, up 11.31% year-over-year. In the fiscal year ending November 30, 2024, Concentrix had annual revenue of $9.62B with 35.20% growth.

• Revenue (ttm): $9.63B
• Revenue Growth: +11.31%
• P/S Ratio: 0.30
• Revenue / Employee: $21.39K
• Employees: 450,000
• Market Cap: 2.52B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Nov 30, 2024	9.62B	2.50B	35.20%
Nov 30, 2023	7.11B	790.23M	12.49%
Nov 30, 2022	6.32B	737.46M	13.20%
Nov 30, 2021	5.59B	867.48M	18.38%
Nov 30, 2020	4.72B	11.62M	0.25%